Home / Inspections / 710185

FDA Inspection 710185 — Everest Life Sciences LLC

Everest Life Sciences LLC — FEI 2243092

The FDA completed an inspection of Everest Life Sciences LLC on February 18, 2011 in Plainsboro, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 18, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Plainsboro, NJ (United States)

Facility

Other inspections at this facility

  • 1267697 (VAI Wed Apr 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1071273 (VAI Tue Oct 23 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1063269 (NAI Fri Jul 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 964002 (NAI Wed Mar 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 778012 (VAI Mon Apr 16 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources